(Press-News.org) Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks, according to preliminary clinical trial data presented today.
The longer nevirapine regimen achieved a 75 percent reduction in HIV transmission risk through breast milk for the infants of HIV-infected mothers with higher T-cell counts who had not yet begun treatment for HIV.
The study was presented at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston.
"Extended breastfeeding reduces infant mortality in places that lack safe, clean water by protecting babies from common childhood diseases because breast milk contains protective antibodies from the mother that formula feeding does not provide," says Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, which funds the trial. "These findings show that giving the infants of HIV-infected mothers an antiretroviral drug daily for the full duration of breastfeeding safely minimizes the threat of HIV transmission through breast milk while preserving the health benefits of extended breastfeeding."
The new findings apply to mothers and infants in developing nations, where infectious diseases such as gastroenteritis and pneumonia often pose a life-threatening risk to very young children. The U.S. Department of Health and Human Services recommends that HIV-infected mothers in the United States feed their babies with infant formula, not breast milk, because safe and affordable formula is available, infant deaths due to infections are low and only total avoidance of breastfeeding will completely protect these infants from HIV transmission through breast milk.
This advanced-stage clinical trial known as HPTN 046 is co-funded by NIAID, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute on Drug Abuse and the National Institute of Mental Health, all part of NIH. The HIV Prevention Trials Network and the International Maternal, Pediatric and Adolescent AIDS Clinical Trials Network are conducting the trial under the leadership of Hoosen Coovadia, M.D., M.B.B.S., of the University of the Witwatersrand in Durban, South Africa. Bonnie Maldonado, M.D., of Stanford University in Stanford, Calif., presented the study results for Dr. Coovadia on March 2, 2011, at CROI.
More than 1,500 mother-infant pairs in South Africa, Tanzania, Uganda and Zimbabwe are participating in HPTN 046, which began in February 2007 and will conclude in July 2011. The participating infants received daily nevirapine for the first six weeks after birth. Those infants who remained free of HIV then were assigned at random to receive either daily nevirapine or a placebo until six months after birth or the cessation of breastfeeding, whichever came first. Study investigators compared the rates of HIV infection in the two groups of infants, and evaluated and compared the safety and tolerance of nevirapine in the infants.
The primary analysis of study data found that 2.4 percent of the infants who received six weeks of nevirapine had acquired HIV through breastfeeding by 6 months of age, but only 1.1 percent of the infants who received six months of nevirapine had acquired HIV through breastfeeding by that time—a 54 percent difference. After the preventive nevirapine regimen was discontinued at six months, however, the rate of subsequent HIV transmission via breastfeeding was the same whether the infants had received daily nevirapine for six weeks or six months.
The percentage of infants who experienced serious health problems was nearly the same in both groups (17 percent in the six-week group and 19 percent in the six-month group). The great majority of these problems were infectious diseases not associated with nevirapine, such as diarrhea, malaria or pneumonia. Only 5 percent of the infants in each group had a health problem that required temporarily stopping daily nevirapine.
In addition, the HPTN 046 study team analyzed the impact of the mother's health and antiretroviral treatment on the benefit of providing daily nevirapine to breastfeeding infants for six months rather than six weeks. One group the investigators evaluated was the infants of mothers who had a T-cell count of at least 350 cells per cubic millimeter of blood, and who thus did not yet require antiretroviral therapy according to World Health Organization guidelines. In these infants, the six-month nevirapine regimen cut HIV transmission through breast milk by 75 percent relative to the six-week regimen.
In infants born to women with a T-cell count lower than 350 cells per cubic millimeter who received antiretroviral therapy for their own health, viral transmission to infants through breast milk was zero or nearly zero regardless of the duration of infant nevirapine.
HIV transmission through breast milk occurred at the highest rates among infants born to mothers who had a T-cell count lower than 350 cells per cubic millimeter but did not receive antiretroviral therapy even though they qualified for it. However, the difference in HIV transmission rates between the two infant drug regimens was not statistically significant.
The investigators will conduct their final analysis of the HPTN 046 study data after all infants have completed 18 months of follow-up this summer.
###
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
6-month drug regimen cuts HIV risk for breastfeeding infants, NIH study finds
2011-03-03
ELSE PRESS RELEASES FROM THIS DATE:
Decline in CP diagnoses in premature infants suggests improvements in perinatal care
2011-03-03
Cincinnati, OH, March 3, 2011 -- Cerebral palsy is a neurodevelopmental condition that affects motor function, more often in children born prematurely. Because cerebral palsy is a result of brain injury received shortly before, during, or soon after birth, the number of infants being diagnosed with the condition is a good indicator of the quality of perinatal and neonatal care. An article soon to be published in the Journal of Pediatrics indicates that the rates of cerebral palsy have declined dramatically in the past 15 years.
Dr. Ingrid van Haastert and colleagues ...
Stigma weighs heavily on obese people, contributing to greater health problems
2011-03-03
WASHINGTON, DC, March 1, 2011 — The discrimination that obese people feel, whether it is poor service at a restaurant or being treated differently in the workplace, may have a direct impact on their physical health, according to new research from Purdue University.
"Obesity is a physiological issue, but when people have negative interactions in their social world—including a sense of being discriminated against—it can make matters worse and contribute to a person's declining physical health," said Markus H. Schafer, the doctoral student in sociology and gerontology who ...
SEO Expert Mike Luchen Has Been Recognized for His Success in Internet Marketing, Social Media and SEO in Westchester County, NY
2011-03-03
Mike Luchen has been recognized for his success in providing solutions to businesses wishing to thrive and grow. Mike has developed the strategies and knowledge required to provide business with the Internet exposure they need reach the level of success they wish quickly and easily.
Mike uses a holistic approach to successful marketing that include the use of SEO SEM online marketing advertising, public relations, social media marketing, Google Maps, Yahoo and local listings. Using the most technologically advanced strategies to generate response to your marketing efforts, ...
Women who miscarry continue to have mental health problems
2011-03-03
The depression and anxiety experienced by many women after a miscarriage can continue for years, even after the birth of a healthy child, according to a study led by University of Rochester Medical Center researchers and published online today by the British Journal of Psychiatry.
"Our study clearly shows that the birth of a healthy baby does not resolve the mental health problems that many women experience after a miscarriage or stillbirth," said Emma Robertson Blackmore, Ph.D., assistant professor of Psychiatry at the Medical Center and the lead researcher. "This finding ...
Sperm quality and counts worsening in Finland
2011-03-03
A new study published in the International Journal of Andrology reveals that semen quality has significantly deteriorated during the last ten years in Finland, a country that previously was a region with high sperm counts. At the same time, the incidence of testis cancer in the Finnish population showed a remarkable increase, following the worrying trends observed in several countries in Europe and the Americas.
Led by Jorma Toppari, MD, PhD, of the University of Turku, researchers examined three cohorts of 19 year old men between the years of 1998 and 2006. The men that ...
New Research from mobileYouth States Brands and Governments Must Co-Create with the World's 1.2 Billion Mobile Youth to Remain Relevant
2011-03-03
Here Come the Mobile Youth: a Generation of Change Agents Under 30
Key findings from the 65 market Mobile Youth Report by consultancy mobileYouth:
- 1.2 billion youth own mobile phones, spending $400 billion annually.
- 60% sleep with their phones. 81% would spend their last $10 on a mobile top-up before food.
- 62% of purchase decisions influenced by peers not traditional paid media.
- Research identified "super-influencers" - fans influencing up to 100 friends in the discovery and education process. Super-influencers were integral in creating change in the Middle ...
Shrinking tundra, advancing forests: how the Arctic will look by century's end
2011-03-03
Imagine the vast, empty tundra in Alaska and Canada giving way to trees, shrubs and plants typical of more southerly climates. Imagine similar changes in large parts of Eastern Europe, northern Asia and Scandinavia, as needle-leaf and broadleaf forests push northward into areas once unable to support them. Imagine part of Greenland's ice cover, once thought permanent, receding and leaving new tundra in its wake.
Those changes are part of a reorganization of Arctic climates anticipated to occur by the end of the 21st century, as projected by a team of University of Nebraska-Lincoln ...
Portable, less costly peritoneal dialysis shows no additional catheter risk factors
2011-03-03
DALLAS – March 3, 2011 – Patients with end-stage renal disease who opt for peritoneal dialysis experience no greater risk of catheter infection than those who undergo hemodialysis, a retrospective study at UT Southwestern Medical Center has found.
Peritoneal dialysis is less costly, easier on the body and provides greater mobility than hemodialysis, the more common procedure in the U.S.
"Patients actually survive better on peritoneal dialysis, have a better quality of life and the procedure is cheaper," said Dr. Ramesh Saxena, associate professor of internal medicine ...
18th Conference on Retroviruses and Opportunistic Infections: Day 4 NIH highlights
2011-03-03
Today was the last day of the 18th Conference on Retroviruses and Opportunistic Infections, a key HIV/AIDS research meeting being held at the Hynes Convention Center in Boston from February 27 through March 2. Highlighted below are selected presentations from March 2nd on research supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), both components of the National Institutes of Health.
Infant HIV Prevention and Treatment
Karin Nielsen-Saines, M.D., ...
DVDNow New Kiosk Operator Boot Camp
2011-03-03
DVDNow Kiosks is a company that goes above and beyond in its dedication to the success of its kiosk owner-operators. From April 14th - 16th, 2011, DVDNow will host the first of many 'Boot Camp' Training Seminars at DVDNow headquarters in beautiful Vancouver, BC. The DVDNow Kiosks Boot Camp is a three-day workshop that will fully train kiosk owner-operators on how to most effectively launch, manage, and ultimately maximize the potential of their DVD rental kiosk business.
The DVDNow Boot Camp will consist of intensive business training, in depth strategy sessions, and ...